Janssen Research & Development has submitted supplemental New Drug Applications (sNDAs) to the US Food and Drug Administration (FDA) for the use of Xarelto (rivaroxaban), an oral anticoagulant. Janssen said the drug is used to treat ...
Tags: Xarelto, rivaroxaban, DVT, pulmonary embolism, VTE
Bayer HealthCare Pharmaceuticals has updated the labels for its drospirenone-containing combination oral contraceptives (COCs) in the US. The revised labels state that COCs containing drospirenone may be associated with a higher risk of ...
Tags: COCs containing drospirenone, VTE, venous thromboembolism